Aurobindo Pharma Ltd

Leading pharmaceutical company with global manufacturing facilities and regulatory approvals.

1986 | Hyderabad, Telangana (India) | Active
Last Updated:

Aurobindo Pharma Profile

Key Indicators

  • Authorised Capital ₹ 666.40 Cr
  • Paid Up Capital ₹ 58.08 Cr
  • Company Age 38 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2,015.00 Cr
  • Satisfied Charges ₹ 4,387.54 Cr
  • Revenue Growth -14.85%
  • Profit Growth 58.82%
  • Ebitda 28.49%
  • Net Worth 10.10%
  • Total Assets 0.88%

About Aurobindo Pharma

Aurobindo Pharma Ltd (APL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 December 1986 and has a history of 38 years and four months. Its registered office is in Hyderabad, Telangana, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524804 and on the National Stock Exchange(NSE) under AUROPHARMA.

The Corporate was formerly known as Aurobindo Pharma Pvt Ltd. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 666.40 Cr and a paid-up capital of Rs 58.08 Cr.

The company currently has active open charges totaling ₹2,015.00 Cr. The company has closed loans amounting to ₹4,387.54 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Aurobindo Pharma Ltd India are Mr Reddy as COMPANY SECRETARY and Mr Ssubramanian as Cfo. Venkata Penaka, Nityananda Kambam, Madan Mettu, and Six other members serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24239TG1986PLC015190

  • Company No.

    015190

  • Stock Symbol

    BSE : 524804 NSE : AUROPHARMA

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    26 Dec 1986

  • Date of AGM

    29 Aug 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Hyderabad

Industry

Pharma
Company report

Aurobindo Pharma Ltd

Explore comprehensive data for Aurobindo Pharma Ltd, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Aurobindo Pharma?

Executive Team (3)

NameDesignationAppointment DateStatus
Mr Reddy Country flag representing In Company SecretaryCurrent
Mr Ssubramanian Country flag representing In CFOCurrent
Nityananda Kambam Country flag representing In Managing Director30-Dec-1992Current

Board Members (8)

NameDesignationAppointment DateStatus
Santanu Mukherjee Country flag representing In Director 09-Feb-2023Current
Deepali Joshi Country flag representing In Director 10-Feb-2024Current
Venkata Penaka Country flag representing In Director 30-Dec-1992Current
Madan Mettu Country flag representing In Whole-Time Director 01-Jan-2013Current
Sarath Penaka Country flag representing In Director 27-Sep-2007Current
Mangalam Kumar Country flag representing In Director 01-Apr-2024Current

Financial Performance of Aurobindo Pharma.

Aurobindo Pharma Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.85% decrease. The company also saw a substantial improvement in profitability, with a 58.82% increase in profit. The company's net worth Soared by an impressive increase of 10.1%.

Aurobindo Pharma revenue growth over time
Aurobindo Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-14.85%
Revenue from Operations
-16.78%
Total Assets
0.88%
Profit or Loss
58.82%
Net Worth
10.10%
EBITDA
28.49%

What is the Ownership and Shareholding Structure of Aurobindo Pharma?

In 2024, Aurobindo Pharma had a promoter holding of 51.84% and a public holding of 48.18%. The company had 17 Subsidiaries, 2 Joint Ventures and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2,015.00 Cr

Satisfied Charges

₹4,387.54 Cr

Charges Breakdown by Lending Institutions

  • State Bank Of India : 2000.00 Cr
  • Export-Import Bank Of India : 15.00 Cr

Latest Charge Details

DateLenderAmountStatus
23 Dec 1999Export-Import Bank Of India₹15.00 CrOpen
05 Jun 1997State Bank Of India₹2,000.00 CrOpen
08 Jan 2013Dbs Bank Ltd₹164.00 CrSatisfied
25 May 2012Ifci Limited₹156.00 CrSatisfied
25 May 2012Ifci Limited₹130.00 CrSatisfied

How Many Employees Work at Aurobindo Pharma?

Aurobindo Pharma has a workforce of 15925 employees as of Aug 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Aurobindo Pharma Ltd

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aurobindo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurobindo Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Aurobindo Pharma

Recent activity within the organization

  • Annual General Meeting

    Aurobindo Pharma Ltd last Annual general meeting of members was held on 29 Aug 2024 as per latest MCA records.

  • Director Appointment

    Mangalam Ramasubramanian Kumar was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 1 month .

  • Balance Sheet

    Aurobindo Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Deepali Pant Rajeev Joshi was appointed as a Director was appointed as a Director on 10 Feb 2024 & has been associated with this company since 1 year 2 months .

  • Director Appointment

    Satakarni Makkapati was appointed as a Director was appointed as a Director on 09 Nov 2023 & has been associated with this company since 1 year 5 months .

  • Charges

    A charge with State Bank Of India of Rs. 2,000.00 Cr registered on 05 Jun 1997 with Charge ID 80013576 was modified on 22 Feb 2023.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Aurobindo Pharma Ltd?

    Aurobindo Pharma Ltd was incorporated on 26 Dec 1986.

  • What is authorized share capital and paid-up capital of Aurobindo Pharma Ltd?

    The authorized share capital of Aurobindo Pharma Ltd is ₹ 666.40 Cr and paid-up capital is ₹ 58.08 Cr.

  • Who are the current board members & directors of Aurobindo Pharma Ltd?

    Currently 11 directors are associated with Aurobindo Pharma Ltd.

    • Mr B Adi Reddy
    • Mr SSubramanian
    • Venkata Ramprasad Reddy Penaka
    • Nityananda Reddy Kambam
    • Madan Mohan Reddy Mettu
    • Sarath Chandra Reddy Penaka
    • Mangalam Ramasubramanian Kumar
    • Deepali Pant Rajeev Joshi
    • Girish Paman Vanvari
    • Santanu Mukherjee
    • Satakarni Makkapati

  • What is the registered address of Aurobindo Pharma Ltd?

    As per Ministry of Corporate Affairs (Mca), the registered address of Aurobindo Pharma Ltd is Plot No.2 Maithrivihar Behind Maithri Vanam Ameerpet, India, Hyderabad, Telangana, 500038.

  • What is the corporate identification number (CIN) and company number of Aurobindo Pharma Ltd?

    The corporate identification number (CIN) of Aurobindo Pharma Ltd is L24239TG1986PLC015190 and the company number is 015190 as per Ministry of Corporate Affairs (MCA).

  • Is Aurobindo Pharma Ltd registered with any stock exchange in India?

    Yes, Aurobindo Pharma Ltd is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): AUROPHARMA.

  • What is the official website of Aurobindo Pharma Ltd?

    The Official website of Aurobindo Pharma Ltd is https://www.aurobindo.com

  • What has been the recent revenue trend for Aurobindo Pharma Ltd?

    According to the financial reports for the fiscal year 2024, the revenue trend for Aurobindo Pharma Ltd has fallen by -14.85%.

  • How many employees does Aurobindo Pharma Ltd currently have?

    As Per 2024 financial reports, 15925 employees are currently employed by Aurobindo Pharma Ltd.

  • What change has been observed in the net worth of Aurobindo Pharma Ltd, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Aurobindo Pharma Ltd has experienced an upsurge of 10.10%.

  • What are the total open charges for Aurobindo Pharma Ltd?

    As per the financial statements for fiscal Year 2024, The total open charges for Aurobindo Pharma Ltd amount to ₹ 2,015.00 Cr.

  • When was the last Balance Sheet of Aurobindo Pharma Ltd filed with the ROC?

    The most recent Balance Sheet for Aurobindo Pharma Ltd was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development